Technology areas: Biotechnology & Pharmaceuticals • Communications
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cellino Biotech Inc. has 3 pending office actions in Biotechnology & Pharmaceuticals. Those matters are distributed among 3 distinct examiners and 3 distinct art units, so prosecution management requires coordination across separate examination assignments.
FITZPATRICK, ATIBA O is the busiest examiner, with 1 pending matter. Because the busiest examiner accounts for only 1 pending matter, no single examiner currently defines the entire response strategy. Counsel should track each office action independently while maintaining consistent positions on related biotechnology claims and disclosures.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FITZPATRICK, ATIBA O | 1 | 87.6% | +6.0% |
| NOBLE, MARCIA STEPHENS | 1 | 67.2% | +39.5% |
| LEITH, NANCY J | 1 | 74.7% | +44.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18951462 | PLATFORMS AND SYSTEMS FOR AUTOMATED CELL CULTURE | FITZPATRICK, ATIBA O | — |
| 18234342 | SYSTEMS AND METHODS FOR CELL MANUFACTURING | NOBLE, MARCIA STEPHENS | — |
| 17267383 | SYSTEM FOR IMAGE-DRIVEN CELL MANUFACTURING | LEITH, NANCY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18234342 | SYSTEMS AND METHODS FOR CELL MANUFACTURING | NOBLE, MARCIA STEPHENS | — |
| 17267383 | SYSTEM FOR IMAGE-DRIVEN CELL MANUFACTURING | LEITH, NANCY J | — |
| Art Unit | Apps |
|---|---|
| 2677 | 1 |
| 1632 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18951462 | PLATFORMS AND SYSTEMS FOR AUTOMATED CELL CULTURE | FITZPATRICK, ATIBA O | 2677 | §103§112 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18234342 | SYSTEMS AND METHODS FOR CELL MANUFACTURING | NOBLE, MARCIA STEPHENS | 1632 | §102§103§112Other | Non-Final OA | — | Pending | Aug 15, 2023 |
| 17267383 | SYSTEM FOR IMAGE-DRIVEN CELL MANUFACTURING | LEITH, NANCY J | 1600 | §103§112Other | Non-Final OA | — | Pending | Feb 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCellino Biotech Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Atiba O Fitzpatrick has the most, with 1 of Cellino Biotech Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
